Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADPH oxidase 4 (NOX4) is an enzyme that belongs to the NOX family of NADPH oxidases. It is responsible for generating reactive oxygen species (ROS), primarily hydrogen peroxide (H2O2), from molecular oxygen using NADPH as an electron donor. NOX4 is involved in various cellular processes including redox homeostasis, oxygen sensing, and signal transduction. Its dysregulation is implicated in cardiovascular diseases, cancer, and metabolic disorders, making it a potential therapeutic target.
Small molecule inhibitors or RNA-based therapies aimed at modulating pathological ROS production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH Oxidase 4.